Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Parallel Session 2401

Choosing a Therapeutic Target: Mitochondria, Lysosome, Proteasome, Nuclear Envelope, or Something Else?

Friday, September 16, 2022
15:00 – 17:00

In this session, the faculty will discuss how malfunction of various intracellular organelles may be linked to the manifestation of Movement Disorders, and how such specific pathways may be targeted for therapeutic purposes.

William Dauer, USA
Leonidas Stefanis, Greece

Vesicular Trafficking in Synucleinopathy Pathogenesis
Mark Cookson, USA

Mitochondrial Dynamics in Parkinson’s Disease Pathogenesis
Ming Guo, USA

Nuclear Envelope-Linked Biology in Dystonia
To Be Announced

CSPC Liaisons:
Leonidas Stefanis, Greece
William Dauer, USA

At the conclusion of this session, participants should be better able to:

  1. Appreciate the evidence linking malfunction of different intracellular components to the pathogenesis of Parkinson’s disease and other movement disorders
  2. Describe how malfunction of such cellular systems may lead to disease manifestation in the nervous system
  3. Learn the latest developments in targeting such malfunctioning cellular systems in Movement Disorders

Recommended Audience:
Clinician/General Neurology, Researcher/Basis Science, Fellow/Resident/Student, Industry

Education Level:


We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice